Annual CFF
$195.88 M
+$195.22 M+29804.73%
December 31, 2024
Summary
- As of March 3, 2025, PRME annual cash flow from financing activities is $195.88 million, with the most recent change of +$195.22 million (+29804.73%) on December 31, 2024.
- During the last 3 years, PRME annual CFF has fallen by -$73.40 million (-27.26%).
- PRME annual CFF is now -27.26% below its all-time high of $269.28 million, reached on December 31, 2021.
Performance
PRME Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$1000.00
-$38.51 M-100.00%
December 31, 2024
Summary
- As of March 3, 2025, PRME quarterly cash flow from financing activities is $1000.00, with the most recent change of -$38.51 million (-100.00%) on December 31, 2024.
- Over the past year, PRME quarterly CFF has dropped by -$157.33 million (-100.00%).
- PRME quarterly CFF is now -100.00% below its all-time high of $157.33 million, reached on March 31, 2024.
Performance
PRME Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$195.88 M
-$193.00 K-0.10%
December 31, 2024
Summary
- As of March 3, 2025, PRME TTM cash flow from financing activities is $195.88 million, with the most recent change of -$193.00 thousand (-0.10%) on December 31, 2024.
- Over the past year, PRME TTM CFF has increased by +$38.35 million (+24.35%).
- PRME TTM CFF is now -0.10% below its all-time high of $196.07 million, reached on September 30, 2024.
Performance
PRME TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
PRME Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +10000.0% | -100.0% | +24.4% |
| 3 y3 years | -27.3% | -100.0% | +24.4% |
| 5 y5 years | +460.7% | -100.0% | +24.4% |
PRME Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -27.3% | >+9999.0% | -100.0% | +100.1% | -0.1% | +5444.5% |
| 5 y | 5-year | -27.3% | >+9999.0% | -100.0% | +100.1% | -0.1% | +5444.5% |
| alltime | all time | -27.3% | >+9999.0% | -100.0% | +100.1% | -0.1% | +5444.5% |
Prime Medicine Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $195.88 M(>+9900.0%) | $1000.00(-100.0%) | $195.88 M(-0.1%) |
| Sep 2024 | - | $38.51 M(>+9900.0%) | $196.07 M(+24.4%) |
| Jun 2024 | - | $35.00 K(-100.0%) | $157.56 M(+0.0%) |
| Mar 2024 | - | $157.33 M(>+9900.0%) | $157.52 M(>+9900.0%) |
| Dec 2023 | $655.00 K(-99.6%) | $194.00 K(-128.4%) | $194.00 K(-105.3%) |
| Dec 2022 | $181.49 M | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$683.00 K(+9.5%) | -$3.67 M(+22.9%) |
| Jun 2022 | - | -$624.00 K(-50.9%) | -$2.98 M(+26.5%) |
| Mar 2022 | - | -$1.27 M(+17.1%) | -$2.36 M(+117.1%) |
| Dec 2021 | $269.28 M(+670.8%) | -$1.09 M(-110.9%) | -$1.09 M(-110.9%) |
| Dec 2020 | $34.93 M | - | - |
| Dec 2019 | - | $9.98 M | $9.98 M |
FAQ
- What is Prime Medicine annual cash flow from financing activities?
- What is the all time high annual CFF for Prime Medicine?
- What is Prime Medicine annual CFF year-on-year change?
- What is Prime Medicine quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Prime Medicine?
- What is Prime Medicine quarterly CFF year-on-year change?
- What is Prime Medicine TTM cash flow from financing activities?
- What is the all time high TTM CFF for Prime Medicine?
- What is Prime Medicine TTM CFF year-on-year change?
What is Prime Medicine annual cash flow from financing activities?
The current annual CFF of PRME is $195.88 M
What is the all time high annual CFF for Prime Medicine?
Prime Medicine all-time high annual cash flow from financing activities is $269.28 M
What is Prime Medicine annual CFF year-on-year change?
Over the past year, PRME annual cash flow from financing activities has changed by +$195.22 M (+29804.73%)
What is Prime Medicine quarterly cash flow from financing activities?
The current quarterly CFF of PRME is $1000.00
What is the all time high quarterly CFF for Prime Medicine?
Prime Medicine all-time high quarterly cash flow from financing activities is $157.33 M
What is Prime Medicine quarterly CFF year-on-year change?
Over the past year, PRME quarterly cash flow from financing activities has changed by -$157.33 M (-100.00%)
What is Prime Medicine TTM cash flow from financing activities?
The current TTM CFF of PRME is $195.88 M
What is the all time high TTM CFF for Prime Medicine?
Prime Medicine all-time high TTM cash flow from financing activities is $196.07 M
What is Prime Medicine TTM CFF year-on-year change?
Over the past year, PRME TTM cash flow from financing activities has changed by +$38.35 M (+24.35%)